Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological principles as a basis for polytherapy

E Perucca1

  • 1Department of Internal Medicine and Therapeutics, University of Pavia, Italy.

Acta Neurologica Scandinavica. Supplementum
|January 1, 1995
PubMed
Summary

For drug-resistant epilepsy, combining anti-epilepsy drugs can improve seizure control. Specific drug combinations, especially with newer agents, offer enhanced efficacy and complementary mechanisms of action.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach.

Acta neurologica Scandinavica·2017
Same author

Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis.

Neuroscience·2012
Same author

Nifedipine versus fenoterol in the management of preterm labor: a randomized, multicenter clinical study.

Gynecologic and obstetric investigation·2012
Same author

Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.

Neurology·2012
Same author

Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.

Epilepsy research·2011
Same author

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.

Neurology·2007

Area of Science:

  • Pharmacology
  • Neurology
  • Clinical Medicine

Background:

  • Epilepsy monotherapy is effective for most newly diagnosed patients.
  • Approximately one-third of patients experience persistent seizures despite maximal tolerated monotherapy.
  • Managing refractory epilepsy often requires combination anti-epilepsy drug therapy.

Purpose of the Study:

  • To explore the therapeutic benefits of specific anti-epilepsy drug combinations.
  • To highlight the importance of understanding drug interactions in polytherapy.
  • To investigate the role of newer anti-epilepsy drugs in combination therapy.

Main Methods:

  • Review of clinical pharmacology principles related to anti-epilepsy drug interactions.
  • Analysis of evidence supporting specific drug combinations (e.g., valproate and ethosuximide).
  • Consideration of mechanisms of action for older and newer anti-epilepsy agents.

Main Results:

  • Specific drug combinations can provide substantial therapeutic benefits in refractory epilepsy.
  • Additive side-effects can occur with older drugs having similar mechanisms of action.
  • Newer anti-epilepsy drugs with selective mechanisms may offer enhanced efficacy in combination therapy.
  • Preliminary evidence suggests complementary pharmacological effects in certain drug combinations.

Conclusions:

  • Combination therapy is a viable strategy for patients with refractory epilepsy.
  • Knowledge of clinical pharmacology and drug interactions is crucial for safe and effective polytherapy.
  • Newer anti-epilepsy drugs may offer improved outcomes when used in carefully selected combinations.

Related Experiment Videos